Spain vs Saint Vincent and the Grenadines: Tuberculosis treatment success rate by type
Spain
61
in 2023
Saint Vincent and the Grenadines
60
in 2022
Spain rank
172nd
Saint Vincent and the Grenadines rank
174th
Tuberculosis treatment success rate by type over time
- Spain
- Saint Vincent and the Grenadines
How they compare
Spain currently reports 61 against 60 in Saint Vincent and the Grenadines, a difference of 1.
The two have swapped places 6 times across 9 shared years of data; in 2010 it was Spain ahead.
Spain ranks 172nd and Saint Vincent and the Grenadines ranks 174th of 194 countries.
Across the 2 decades both report, Spain averaged higher in 1 and Saint Vincent and the Grenadines in 1.
Head to head by decade
| Decade | Spain | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 60.5 | 51.33 | 9.17 | Spain |
| 2020s | 54.67 | 55.33 | 0.6667 | Saint Vincent and the Grenadines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Spain or Saint Vincent and the Grenadines?
- Spain, at 61 against 60 in Saint Vincent and the Grenadines as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Spain and Saint Vincent and the Grenadines?
- 1, with Spain ahead.
- How many years of comparable data are there for Spain and Saint Vincent and the Grenadines?
- 9 years are reported by both, from 2010 to 2022.
- How do Spain and Saint Vincent and the Grenadines rank globally for tuberculosis treatment success rate by type?
- Spain ranks 172nd and Saint Vincent and the Grenadines ranks 174th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.